Dr. Goldmacher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
320 Bent St
Cambridge, MA 02141
Summary
- Physician, scientist, executive, and entrepreneur focused on clinical development, medical imaging, artificial intelligence, and biomarker applications, with growing experience in pharmaceutical business development (M&A) and financial strategy.
Education & Training
Temple University Fox School of BusinessMBA, 2012 - 2015
University of Texas Southwestern Medical SchoolClass of 2001, MD, PhD- University of ChicagoBA, Biological Sciences
Certifications & Licensure
MA State Medical License 2007 - 2024
PA State Medical License 2008 - 2009
Publications & Presentations
PubMed
- 48 citationsEarly Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy Using a Novel Imaging Analysis.Laurent Dercle, Binsheng Zhao, Mithat Gönen, Chaya S Moskowitz, Ahmed Firas
JAMA Oncology. 2022-03-01 - 9 citationsDeep learning for classification of pediatric chest radiographs by WHO's standardized methodology.Yiyun Chen, Craig S. Roberts, Wanmei Ou, Tanaz Petigara, Gregory V. Goldmacher
Plos One. 2021-06-21 - 14 citationsComparing RECIST 1.1 and iRECIST in advanced melanoma patients treated with pembrolizumab in a phase II clinical trialFiras S. Ahmed, Laurent Dercle, Gregory V. Goldmacher, Hao Yang, Dana E. Connors
European Radiology. 2021-04-01
Journal Articles
- Response Criteria for Intratumoral Immunotherapy in Solid Tumors: itRECISTGregory V. Goldmacher, MD, PhD, MBA; Anuradha D. Khilnani, MD; Robert H. I. Andtbacka, MD; Jason J. Luke, MD; F. Stephen Hodi, MD; Aurelien Marabelle, MD, PhD; Kevin H..., Journal of Clinical Oncology, 6/18/2020
Press Mentions
Gregory Goldmacher, MD, PhD, MBA, on New Response Criteria for Intratumoral ImmunotherapyAugust 6th, 2020
Committees
- Co-chair, Immunotherapy Subcommittee, RECIST Working Group 2021 - Present
- Steering Committee, Modality Committee Co-Chair, CT Volumetry Committee Co-Chair, Quantitative Imaging Biomarkers Alliance
- Steering committee, Pharmaceutical Imaging Network for Therapeutics and Diagnostics (PINTAD)
Professional Memberships
- Member
- Member
Other Languages
- Russian, French, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
